360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial vulnerability assessment tool by 360 Security Group (Qihoo 360). CyberScope Edge is a commercial vulnerability assessment tool by CyberScope by NetAlly. Compare features, ratings, integrations, and community reviews side by side to find the best vulnerability assessment fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Field security teams conducting physical network audits will get the most from CyberScope Edge because its handheld form factor lets you scan wired and wireless infrastructure on-site without hauling laptops or waiting for remote assessments. The device delivers connected device discovery and vulnerability reporting from the device itself, cutting the dependency on centralized scan infrastructure. Skip this if your organization needs continuous cloud-based risk monitoring or doesn't have regular on-premises network assessment requirements; CyberScope Edge is built for tactile, boots-on-the-ground vulnerability work.
Tool that immunizes Windows systems against critical vulnerabilities
Handheld hardware device for on-site network vulnerability scanning.
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs CyberScope Edge for your vulnerability assessment needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). headquartered in China. Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
CyberScope Edge: Handheld hardware device for on-site network vulnerability scanning. built by CyberScope by NetAlly. headquartered in United States. Core capabilities include Network vulnerability scanning, Connected device discovery, Wired network security assessment..
Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.
Get strategic cybersecurity insights in your inbox